Description: This session from the 1995 SOA Boston Meeting explores reinsurance from the ceding company's perspective including a view from a large, medium and small insurance company. Topics include reasons to reinsure, factors in the reinsurance process, how to select a reinsurer and changes in the process. From the Record of the Society of Actuaries, Vol. 21, No. 4b.

Description: This presentation is an open forum, session number 21OF, from the 2002 Valuation Actuary Symposium, held September 19-20 in Lake Buena Vista, FL. In this open forum, the panelists address the requirements under statutory codification, and the approaches being used to meet these requirements. Topics include policy classification, deferred taxes, disclosure, state differences, and implementation issues. Discussion from participants is included.

Description: As the size of the life reinsurance market in Bermuda has grown to over half a trillion dollars at the end of 2021, more and more actuaries are getting involved with this 21 square mile North Atlantic island in one way or the other. Come explore a fundamental understanding of the Bermuda solvency framework and an overview of its upcoming changes.

Description: Explore various aspects of the Asian reinsurance market in this webcast. Learn about the landscape within the market as speakers cover key topics like product perspectives, structured solutions and emerging trends and issues. Take an in-depth look at the post COVID-19 impact, as well as regulatory considerations that could affect the Asian reinsurance industry. Secure your spot in this opportunity and dive into the direction of this marketspace.

Description: This session from the 1995 SOA Boston Meeting presents the issues in developing a reinsurance arrangement for fixed annuity products including rate crediting strategies, reinsurer solvency risk, fund management and regulatory issues. Also included is reinsurance of interest sensitive products, variable life and annuity and terminal funding. From the Record of the Society of Actuaries, Vol. 21, No. 4a.

Description: Essay offers a vision of health care where everyone is covered, everyone is eligible, receives fair pricing, receives vital information and is taxed the same.

Description: Articles on IRS private letter rulings on combination products, IRS treatment of reinsurance under section 845, and IRS waivers for failed contracts under section 7702.

Description: Gene therapy is a quickly evolving field and will continue to grow as a risk concern for many health plans, stop loss insurers and reinsurers. Currently, there are only two approved gene therapies in the U.S., but that number is expected to escalate starting in the fall of 2022. Revisit the experience plans have had with the first two gene therapies, discuss plan design and network considerations in light of gene therapy, and discuss the actual composition of the near-term pipeline along with a range of modeled financial impacts and considerations for payers.

Description: Presented at October 1985 Annual Meeting. Discusses new state and NAIC regulation of surplus relief reinsurance, GAAP treatment of reinsurance, and taxation of reinsurance under Section 845 of the 1984 Tax Law.

Description: Reinsurance is a global business, yet reinsurers suffer from widely disparate accounting and regulatory requirements from jurisdiction to jurisdiction, particularly in the areas of credit for reinsurance and collateral requirements. Recently, insurance regulators in the United States and worldwide have taken dramatic steps toward harmonization, mutual recognition and regulatory cooperation in connection with regulation of reinsurance, with a focus on modernizing collateral requirements.